| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
2 companies
Orbimed Israel GP Ltd. is a 10% Owner at CMMB, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 3 sales. Those positions are worth an estimated $9.3M at current prices.
Orbimed Israel GP Ltd.'s largest disclosed position is in CMMB as 10% Owner, worth about $7.7M. The recent filings there lean toward selling, a net 336,900 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | CMMB Chemomab Therapeutics Ltd. | 10% Owner | Sell | 336,900 | $3.58 | $1,207,759.08 | -13.1% | -49.0% | -81.8% | |
| Dec 2, 2020 | ELDN Eledon Pharmaceuticals, Inc. | 10% Owner | Sell | 103,200 | $21.60 | $2,229,120.00 | -58.4% | - | - | |
| May 2, 2019 | ELDN Eledon Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 646,204 | $3.10 | $2,003,232.40 | +25.5% | - | - |